Intravenous Tissue Plasminogen Activator Thrombolysis in Patients without Major Arterial Occlusion Seems to Be Safe and Effective

Publisher： Karger

E-ISSN： 1421-9913|64|5|258-264

ISSN： 0014-3022

Source： European Neurology, Vol.64, Iss.5, 2010-10, pp. : 258-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Dabigatran

By  

Cerebrovascular Diseases, Vol. 30, Iss. 5, 2010-09 ,pp. : 533-534

Karger

Access to resources Recommend Favorite

Validation of FLAIR Hyperintense Lesions as Imaging Biomarkers to Predict the Outcome of Acute Stroke after Intra-Arterial Thrombolysis following Intravenous Tissue Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 35, Iss. 5, 2013-05 ,pp. : 461-468

Karger

Access to resources Recommend Favorite

Endovascular Treatment in Patients with Persistent Internal Carotid Artery Occlusion after Intravenous Tissue Plasminogen Activator: A Clinical Effectiveness Study

By  

Cerebrovascular Diseases, Vol. 42, Iss. 5-6, 2016-07 ,pp. : 387-394

Karger

Access to resources Recommend Favorite

Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time

By  

Cerebrovascular Diseases Extra, Vol. 3, Iss. 1, 2013-03 ,pp. : 35-45

Karger

Access to resources Recommend Favorite

Vascular Aphasia Outcome after Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Ischemic Stroke

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 288-295

Karger

Access to resources Recommend Favorite